RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

Details for Australian Patent Application No. 2007238027 (hide)

Owner Alcon Research, Ltd.

Inventors Yanni, John M.; Chatterton, Jon E.; Gamache, Daniel A.; Miller, Steven T.

Agent Shelston IP

Pub. Number AU-A-2007238027

PCT Pub. Number WO2007/121347

Priority 60/791,847 13.04.06 US

Filing date 13 April 2007

Wipo publication date 25 October 2007

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/121347 Priority application(s): WO2007/121347

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238028-Business form comprising a wristband

2007238019-Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors